Up to 40% of ED visits include diagnostic blood tests and 26% result in administration of IV fluids necessitating successful peripheral intravenous (IV) catheter placement. 1 There is a subset of patients with difficult IV access (DIVA) in which traditional cannulation methods are unsuccessful resulting in central venous cannulation (CVC).
CVCs have a 5-15 percent complication rate 2 and attributable costs per CVC related infection have been estimated at $34,508-$56,000. 3 Ultrasound-guided peripheral IV catheters (USGPIVs) provide a method of potentially decreasing the need for CVC placement, however due to poor durability of USGPIVs the actual reduction in CVCs is unclear.
INTRODUCTION
Study Design: Prospective observational study of patients with difficult IV access.
Setting:
Two urban Emergency Departments with annual censuses of 65,000 and 40,000. Enrollment occurred from November 2010 -June 2011.
Population:
Convenience sample of patients with at least two failed peripheral IV attempts plus a failure to establish extrajugular access (failure, patient refusal, or inability to lay supine) determined to require CVC for IV access if ultrasound was not available were included. Patients were excluded if unable to give verbal consent, if CVC was determined to be required for patient stabilization or if the caring physician indicated that a CVC would not be necessary despite the failure to establish peripheral IV access.
Protocol: USGPIVs were placed by ED physicians at all levels of training. All USGPIVs were 20GA 48mm long catheters placed using a Sonosite Micromaxx or M-Turbo (Sonosite Inc., Bothell, WA) high-frequency linear array transducer. Patients were followed for 7 days or until hospital discharge to assess for subsequent central venous access and related complications. Four (4.0%, 95 CI: 1.6-9.8%) patients had documented complications due to USGPIV (3 extravasation of fluids, 1 extravasation of IV contrast).
METHODS

RESULTS
Figure 1: USGPIV placement and outcomes
One patient in the CVC group developed a catheter related infection resulting in a 6.7% (95 CI: 1.2-29.8%) complication rate.
LIMITATIONS
No randomization or blinding.
Underpowered to assess the true complication rates of CVCs.
Potential bias in determining necessity of central venous access.
CONCLUSIONS
Ultrasound prevents the need for central venous access in approximately 85% of patients with difficult IV access.
Assuming a standard CVC complication rate of 5-15% in the DIVA cohort, by avoiding CVC placement in 85% of this cohort, USGPIVs potentially reduce significant complications of CVCs in this cohort down to 0.75-2.3%.
For every eight patients with DIVA that get an USGPIV instead of a CVC, at least one CVC complication is avoided
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